GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Think Research Corp (OTCPK:THKKF) » Definitions » COGS-to-Revenue

Think Research (Think Research) COGS-to-Revenue : 0.55 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Think Research COGS-to-Revenue?

Think Research's Cost of Goods Sold for the three months ended in Sep. 2023 was $7.74 Mil. Its Revenue for the three months ended in Sep. 2023 was $14.18 Mil.

Think Research's COGS to Revenue for the three months ended in Sep. 2023 was 0.55.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Think Research's Gross Margin % for the three months ended in Sep. 2023 was 45.40%.


Think Research COGS-to-Revenue Historical Data

The historical data trend for Think Research's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Think Research COGS-to-Revenue Chart

Think Research Annual Data
Trend Sep20 Dec21 Dec22
COGS-to-Revenue
0.39 0.49 0.52

Think Research Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 0.53 0.48 0.48 0.55

Think Research COGS-to-Revenue Calculation

Think Research's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=30.34 / 57.861
=0.52

Think Research's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=7.743 / 14.182
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Think Research  (OTCPK:THKKF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Think Research's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 7.743 / 14.182
=45.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Think Research COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Think Research's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Think Research (Think Research) Business Description

Traded in Other Exchanges
Address
199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9
Think Research Corp and its subsidiaries are a healthcare technology company digitalizing the delivery of knowledge to facilitate better healthcare outcomes. The company gathers, develops, and delivers a knowledge-based Software-as-a-Service solution globally to customers which typically includes enterprise clients, hospitals, health regions, healthcare professionals, and/or governments. Its cloud-based, EMR-agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care, including primary physician care, acute care hospitals and surgical suites as well as community and senior care.